HLA-DRB1 and hepatocellular carcinoma: We therefore develop a working hypothesis that if involved, the mutation of rs17879599 via altering the binding ability of HLA-DRB1 to its antigens could provide a possible molecular mechanism to explain inter-individual variation in predisposition to HCC.